Medra Corporation
MDRA · OTC
6/30/2002 | 3/31/2002 | 12/31/2001 | 9/30/2001 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -9.2% | -55.1% | 87.9% | – |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | -126% | 8% | -36.2% | 29.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -837.1% | -676.7% | -477.8% | -845% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,012.2% | -697% | -472.4% | -899.4% |
| EPS Diluted | -50 | -40 | -68.2 | -80 |
| % Growth | -25% | 41.3% | 14.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |